Patents by Inventor Antonio Trilli

Antonio Trilli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Low-Molecular-Weight Biotechnological Chondroitin 6-Sulphate for Prevention of Osteoarthritis
    Publication number: 20160074429
    Abstract: Disclosed is a low-molecular-weight (1000-5000 daltons) chondroitin sulphate (CS) produced by chemical sulphation and subsequent depolymerisation of a non-sulphated chondroitin backbone obtained with biotechnology techniques. The CS described is substantially monosulphated, mainly at the 6-position, with very little sulphation at the 4-position, and with a mono/disulphated disaccharide ratio and charge density similar to those of natural CS. Said biotechnological chondroitin 6-sulphate (C6S) is useful in the treatment and prevention of osteoarthritis and in acute and chronic inflammatory processes.
    Type: Application
    Filed: November 20, 2015
    Publication date: March 17, 2016
    Applicant: GNOSIS S.P.A.
    Inventors: Niccolo Miraglia, Davide Bianchi, Ermanno Valoti, Antonella Trentin, Antonio Trilli, Immacolata Busiello, Marco Agostinetto, Paola Bazza, Marco Valetti
  • Low-Molecular-Weight Biotechnological Chondroitin 6-Sulphate for Prevention of Osteoarthritis
    Publication number: 20150152198
    Abstract: Disclosed is a low-molecular-weight (1000-5000 daltons) chondroitin sulphate (CS) produced by chemical sulphation and subsequent depolymerisation of a non-sulphated chondroitin backbone obtained with biotechnology techniques. The CS described is substantially monosulphated, mainly at the 6-position, with very little sulphation at the 4-position, and with a mono/disulphated disaccharide ratio and charge density similar to those of natural CS. Said biotechnological chondroitin 6-sulphate (C6S) is useful in the treatment and prevention of osteoarthritis and in acute and chronic inflammatory processes.
    Type: Application
    Filed: May 22, 2013
    Publication date: June 4, 2015
    Inventors: Niccolo Miraglia, Davide Bianchi, Ermanno Valoti, Antonella Trentin, Antonio Trilli, Immacolata Busiello, Marco Agostinetto, Paola Bazza, Marco Valetti
  • Biotechnological production of chondroitin
    Patent number: 8771992
    Abstract: Chondroitin is produced by culturing a recombinant microorganism which is obtained by inactivation of a gene encoding an enzyme responsible for addition of fructose residues to the linear chondroitin polysaccharide in a microorganism producing a fructosylated derivative of chondroitin.
    Type: Grant
    Filed: November 13, 2013
    Date of Patent: July 8, 2014
    Assignee: GNOSIS S.p.A.
    Inventors: Antonio Trilli, Immacolata Busiello, Simona Daly, Francesca Bagatin
  • Process for the biologic treatment of organic wastes and plant therefor
    Patent number: 8734647
    Abstract: Process for the biological treatment of organic wastes, includes a first anaerobic digestion phase and a second aerobic digestion phase in succession, a respective filtration phase of the solid substance being provided between the two digestion phases, a separation phase of the biogas released in the anaerobic digestion phase and a nitrogen recovery phase from the exhaust gases rich in ammoniac substances separated from the aerobic digestion phase. The solid substance coming from each of the filtration phases is separately returned to the respective digestion phase, while the liquid phase coming from the filtration phase downstream of the anaerobic digestion phase is sent to aerobic phase. In the nitrogen recovery phase the gaseous current consisting of exhaust gases rich in ammoniac substances is treated with a solution of carbonic acid supplied in countercurrent in a first gas/liquid contactor to obtain a mixture of nitrogen salts (ammonium bicarbonate, ammonium carbonate, etc.).
    Type: Grant
    Filed: May 17, 2010
    Date of Patent: May 27, 2014
    Assignee: Bioenergia S.r.l.
    Inventors: Paolo Bresciani, Andrea Manfredini, Andrea Peri, Federico Peri, Mario Peri, Vanessa Pizzaballa, Martino Pretalli, Antonio Tabarelli, Antonio Trilli
  • Biotechnological Production of Chondroitin
    Publication number: 20140073772
    Abstract: Chondroitin is produced by culturing a recombinant microorganism which is obtained by inactivation of a gene encoding an enzyme responsible for addition of fructose residues to the linear chondroitin polysaccharide in a microorganism producing a fructosylated derivative of chondroitin.
    Type: Application
    Filed: November 13, 2013
    Publication date: March 13, 2014
    Applicant: GNOSIS S.P.A.
    Inventors: Antonio Trilli, Immacolata Busiello, Simona Daly, Francesca Bagatin
  • Biotechnological production of chondroitin
    Patent number: 8609394
    Abstract: Chondroitin is produced by culturing a recombinant microorganism which is obtained by inactivation of a gene encoding an enzyme responsible for addition of fructose residues to the linear chondroitin polysaccharide in a microorganism producing a fructosylated derivative of chondroitin.
    Type: Grant
    Filed: June 24, 2011
    Date of Patent: December 17, 2013
    Assignee: Gnosis S.p.A.
    Inventors: Antonio Trilli, Immacolata Busiello, Simona Daly, Francesca Bagatin
  • Biotechnological Production of Chondroitin
    Publication number: 20120010399
    Abstract: Chondroitin is produced by culturing a recombinant microorganism which is obtained by inactivation of a gene encoding an enzyme responsible for addition of fructose residues to the linear chondroitin polysaccharide in a microorganism producing a fructosylated derivative of chondroitin.
    Type: Application
    Filed: June 24, 2011
    Publication date: January 12, 2012
    Applicant: GNOSIS S.P.A.
    Inventors: Antonio Trilli, Immacolata Busiello, Simona Daly, Francesca Bagatin